Please login to the form below
BrightGene
This page shows the latest BrightGene news and features for those working in and with pharma, biotech and healthcare.
UPDATED: Gilead drops remdesivir’s orphan drug designation
Chinese pharma company BrightGene also alleged that it had successfully copied remdesivir and had plans to manufacture a generic version of the drug. ... The SSE said that BrightGene had not gained approval from China’s drug regulator to manufacture
Latest news
-
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in US
Chinese pharma company BrightGene also entered the mix after reporting earlier this month that it had successfully copied remdesivir, and has begun manufacturing the generic version.
-
Moderna and GSK advance coronavirus vaccine candidates
Although Gilead allegedly owns all patents for the drug, including for coronaviruses, that did not stop Chinese pharma company BrightGene from successfully copying the drug for use in China. ... However, despite successfully copying and manufacturing the
-
China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir
BrightGene has only been able to make small quantities of the drug, rather than the enough for commercial sale, which it had originally claimed. ... China. Following its announcement, BrightGene saw its share climb 20%, increasing to RMB 52.12 ($7.48)
-
Citryll snares €15m backing for its autoimmune disease NETs
The 15m in Series A funding, backed by ModiQuest, BOM Brabant Ventures, BrightGene, and Curie Capital, will be used to progress Citryll’s tACPA antibodies through preclinical and clinical development.
More from news
Approximately 1 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
